Table 3.

CD4⁺ and CD8⁺ T_EM and T_N cells in patients relative to donors.

	Donor HCMV+ PBMCs	Donor HCMV− PBMCs	Patient HCMV+PBMCs	Patient HCMV−PBMCs	Patient HCMV+biopsy	Patient HCMV−biopsy
	(n= 9)	(n = 7)	(n = 17)	(n = 2)	(n = 13)	(n = 2)	Statistical analysis
% of CD4+EM	30.1 ± 5.1	18.7 ± 1.2	42.3 ± 5.1	25.2	62.1 ± 4.1	70.7	Two-way ANOVA, Bonferroni's multiple comparison test:
							P < 0.01 for Donor HCMV+ vs. patient HCMV− biopsy,
							P < 0.0001 for Donor HCMV+ vs. patient HCMV+ biopsy,
							P < 0.0001 for Donor HCMV− vs. patient HCMV− biopsy,
							P < 0.0001 for Donor HCMV− vs. patient HCMV+ biopsy,
							P < 0.01 for Donor HCMV− vs. patient HCMV+ PBMC,
							P < 0.05 patients' HCMV− PBMC vs. patient HCMV− biopsy
							P < 0.01 patients' HCMV+ PBMC vs. patient HCMV+ biopsy and
							P < 0.01 patients' HCMV− PBMC vs. patient HCMV+ biopsy
% of CD4+N	36.6 ± 5.1	44.9 ± 2.1	19.4 ± 3.8	27.7	5.2 ± 1.9	4.1	Two-way ANOVA, Bonferroni's multiple comparison test:
							P < 0.05 for Donor HCMV+ vs. patient HCMV− biopsy,
							P < 0.001 for Donor HCMV+ vs. patient HCMV+ biopsy,
							P < 0.05 for Donor HCMV+ vs. patient HCMV− biopsy,
							P < 0.01 for Donor HCMV− vs. patient HCMV− biopsy,
							P < 0.0001 for Donor HCMV− vs. patient HCMV+ biopsy and
							P < 0.001 for Donor HCMV− vs. patient HCMV+ PBMC
% of CD8+EM	25.9 ± 4.2	16.6 ± 3.5	28.1 ± 4.1	22.1	52.1 ± 5.6	54.0	Two-way ANOVA, Bonferroni's multiple comparison test:
							P < 0.001 for Donor HCMV+ PBMC vs. patient HCMV+ biopsy, P < 0.05 for Donor HCMV−PBMC vs. patient HCMV− biopsy,
							P < 0.0001 for Donor HCMV−PBMC vs. patient HCMV+ biopsy and
							P < 0.0001 for patients' HCMV+ biopsy vs. patient HCMV+ PBMC
% of CD8+N	26.9 ± 5.7	40.60 ± 5.5	26.9 ± 4.4	21.1	10.9 ± 2.8	0.8	Two-way ANOVA, Bonferroni's multiple comparison test :
							P < 0.01 for Donor HCMV−PBMC vs. patient HCMV− biopsy and P < 0.001 for Donor HCMV−PBMC vs. patients HCMV+ biopsy